Skip to Content
Merck
CN
  • ERP grants first action status to candidate tissue residue methods for high-priority animal drugs.

ERP grants first action status to candidate tissue residue methods for high-priority animal drugs.

Journal of AOAC International (2012-09-14)
Mark R Coleman
MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Narasin from Streptomyces auriofaciens, ≥98% (HPLC)